Article info
PDFImage of the moment
Erdheim-Chester disease presenting as precipitous cognitive decline
- Correspondence to Dr Ross Penninkilampi, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia; ross.penninkilampi{at}health.nsw.gov.au
Citation
Erdheim-Chester disease presenting as precipitous cognitive decline
Publication history
- Accepted September 27, 2022
- First published October 25, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (28 April 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- An unusual case of interstitial lung disease in a patient with cardiopulmonary syndrome as the initial presentation of Erdheim-Chester disease
- Peritoneal or mesenteric tumours revealing histiocytosis
- Erdheim-Chester disease: a rare cause of bilateral renal artery stenosis, mimicking large vessel vasculitis
- 4CPS-122 Efficacy and safety of cobimetinib used in monotherapy for erdheim–chester disease
- Efficacy of infliximab in the treatment of Erdheim-Chester disease
- The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases
- Erdheim-Chester disease: an unusual aetiology of bilateral lipomatous perinephric masses
- Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions
- Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib
- Erdheim-Chester disease with isolated craniocerebral involvement